SOURCE: Reuters India has privately raised objections to Chinese firm Shanghai Fosun Pharmaceutical Group’s (600196.SS) proposed $1.3 billion takeover of Indian drugmaker Gland Pharma, a source familiar with the matter said on Monday. The deal has won the approval of the Competition Commission of India (CCI) and India’s Foreign Investment Promotion Board (FIPB) in the last […]
The post India raises concerns around Chinese firm Fosun’s takeover of Gland-source appeared first on Indian Defence Research Wing.
from Indian Defence Research Wing http://ift.tt/2uSQLHb
via IFTTThttp://idrw.org
No comments:
Post a Comment